谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

652P 3-Year Follow-Up of a Phase III Study to Compare Efficacy and Safety of a Bevacizumab Biosimilar, CT-P16, and Reference Bevacizumab As First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

C. Verschraegen,Z.G. Andric,F.V. Moiseenko,T. Makharadze, A. Oleksiienko, E.P. Yanez Ruiz, S.H. Kim,K. Ahn,T.H. Park, H.A. Ju, E.H. Baek, S. Kwon, S.J. Lee, I. Chang,H.A. Kim, E. Lee,Y. Ohe

Annals of Oncology（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要